Pyrocincholic acid 3β-O-β-D-quinovopyranosyl-28-O-β-D-glucopyranoside suppresses adipogenesis and regulates lipid metabolism in 3T3-L1 adipocytes

Natural Products and Bioprospecting
Li PengWenyong Xiong

Abstract

Obesity is crucially involved in many metabolic diseases, such as type 2 diabetes, cardiovascular disease and cancer. Regulating the number or size of adipocytes has been suggested to be a potential treatment for obesity. In this study, we investigated the effect of pyrocincholic acid 3β-O-β-D-quinovopyranosyl-28-O-β-D-glucopyranoside (PAQG), a 27-nor-oleanolic acid saponin extracted from Metadina trichotoma, on adipogenesis and lipid metabolism in 3T3-L1 adipocytes. The 3T3-L1 pre-adipocytes were incubated with vehicle or PAQG for 6 days in differentiation process. PAQG significantly reduced the adipogenesis, adiponectin secretion and the expression level of key transcription factors related to adipogenesis, such as PPARγ, C/EBPβ, C/EBPα, and FABP4. Moreover, PAQG increased the levels of FFA and glycerol in medium and reduced TG level in mature adipocytes. Interestingly, PAQG not only promoted the activation of AMPK and genes involved in fatty oxidation including PDK4 and CPT1a, but also inhibited those genes involved in fatty acid biosynthesis, such as SREBP1c, FAS, ACCα and SCD1. In conclusion, PAQG inhibits the differentiation and regulates lipid metabolism of 3T3-L1 cells via AMPK pathway, suggesting that PAQG may be a nov...Continue Reading

References

Apr 15, 2000·Nature·P G Kopelman
Jan 4, 2001·The Journal of Nutrition·J M Ntambi, K Young-Cheul
Dec 2, 2006·Nature Reviews. Molecular Cell Biology·Evan D Rosen, Ormond A MacDougald
Mar 28, 2009·PLoS Computational Biology·Junghyo JoVipul Periwal
Mar 4, 2010·Cell Metabolism·Dawn L Brasaemle
Oct 22, 2010·Chemistry & Biodiversity·Biswanath DindaYoshihiro Harigaya
Apr 3, 2012·Annual Review of Biochemistry·Qi Qun Tang, M Daniel Lane
Feb 12, 2014·Pakistan Journal of Biological Sciences : PJBS·W Y Liu, R S Jiang
Mar 4, 2015·Nature Reviews. Endocrinology·Peter Arner, Agné Kulyté
Apr 23, 2016·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Quancai SunYeonhwa Park

❮ Previous
Next ❯

Citations

May 25, 2020·Natural Products and Bioprospecting·Hui-Min ZhouWen-Yong Xiong

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
Assay
protein assay

Software Mentioned

Metamorph

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.